These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38996180)

  • 1. Redefining a new frontier in alkaptonuria therapy with AI-driven drug candidate design via
    Naveed M; Javed K; Aziz T; Zafar A; Fatima M; Ali I; Khan AA; Albekairi TH
    Z Naturforsch C J Biosci; 2024 Jul; ():. PubMed ID: 38996180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Potential Inhibitors for the Treatment of Alkaptonuria Using an Integrated In Silico Computational Strategy.
    Zaib S; Rana N; Hussain N; Ogaly HA; Dera AA; Khan I
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria.
    Laschi M; Bernardini G; Dreassi E; Millucci L; Geminiani M; Braconi D; Marzocchi B; Botta M; Manetti F; Santucci A
    ChemMedChem; 2016 Apr; 11(7):674-8. PubMed ID: 26947423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Intelligence Assisted Pharmacophore Design for Philadelphia Chromosome-Positive Leukemia with Gamma-Tocotrienol: A Toxicity Comparison Approach with Asciminib.
    Naveed M; Ain NU; Aziz T; Javed K; Shabbir MA; Alharbi M; Alsahammari A; Alasmari AF
    Biomedicines; 2023 Mar; 11(4):. PubMed ID: 37189659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone.
    Preston AJ; Keenan CM; Sutherland H; Wilson PJ; Wlodarski B; Taylor AM; Williams DP; Ranganath LR; Gallagher JA; Jarvis JC
    Ann Rheum Dis; 2014 Jan; 73(1):284-9. PubMed ID: 23511227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of alkaptonuria.
    Fernández-Cañón JM; Granadino B; Beltrán-Valero de Bernabé D; Renedo M; Fernández-Ruiz E; Peñalva MA; Rodríguez de Córdoba S
    Nat Genet; 1996 Sep; 14(1):19-24. PubMed ID: 8782815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homogentisate 1,2-dioxygenase (HGD) gene variants, their analysis and genotype-phenotype correlations in the largest cohort of patients with AKU.
    Ascher DB; Spiga O; Sekelska M; Pires DEV; Bernini A; Tiezzi M; Kralovicova J; Borovska I; Soltysova A; Olsson B; Galderisi S; Cicaloni V; Ranganath L; Santucci A; Zatkova A
    Eur J Hum Genet; 2019 Jun; 27(6):888-902. PubMed ID: 30737480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation in the homogentisate 1,2 dioxygenase gene identified in Chinese Hani pediatric patients with Alkaptonuria.
    Tao L; Deng C; Ma M; Zhang Y; Duan J; Li Y; Fang L; Zhou Y; He X; Wang Y; Wang M; Li L
    Clin Chim Acta; 2022 Jul; 532():164-171. PubMed ID: 35550814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients.
    Beltrán-Valero de Bernabé D; Granadino B; Chiarelli I; Porfirio B; Mayatepek E; Aquaron R; Moore MM; Festen JJ; Sanmartí R; Peñalva MA; de Córdoba SR
    Am J Hum Genet; 1998 Apr; 62(4):776-84. PubMed ID: 9529363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary restriction of tyrosine and phenylalanine lowers tyrosinemia associated with nitisinone therapy of alkaptonuria.
    Hughes JH; Wilson PJM; Sutherland H; Judd S; Hughes AT; Milan AM; Jarvis JC; Bou-Gharios G; Ranganath LR; Gallagher JA
    J Inherit Metab Dis; 2020 Mar; 43(2):259-268. PubMed ID: 31503358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkaptonuria: Current Perspectives.
    Zatkova A; Ranganath L; Kadasi L
    Appl Clin Genet; 2020; 13():37-47. PubMed ID: 32158253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum markers in alkaptonuria: simultaneous analysis of homogentisic acid, tyrosine and nitisinone by liquid chromatography tandem mass spectrometry.
    Hughes AT; Milan AM; Davison AS; Christensen P; Ross G; Gallagher JA; Dutton JJ; Ranganath LR
    Ann Clin Biochem; 2015 Sep; 52(Pt 5):597-605. PubMed ID: 25628464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of alkaptonuria.
    Phornphutkul C; Introne WJ; Perry MB; Bernardini I; Murphey MD; Fitzpatrick DL; Anderson PD; Huizing M; Anikster Y; Gerber LH; Gahl WA
    N Engl J Med; 2002 Dec; 347(26):2111-21. PubMed ID: 12501223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic studies in the inborn error of metabolism alkaptonuria reveal new biotransformations in tyrosine metabolism.
    Norman BP; Davison AS; Hughes JH; Sutherland H; Wilson PJ; Berry NG; Hughes AT; Milan AM; Jarvis JC; Roberts NB; Ranganath LR; Bou-Gharios G; Gallagher JA
    Genes Dis; 2022 Jul; 9(4):1129-1142. PubMed ID: 35685462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-onset ocular ochronosis in a girl with alkaptonuria (AKU) and a novel mutation in homogentisate 1,2-dioxygenase (HGD).
    Gucev ZS; Slaveska N; Laban N; Danilovski D; Tasic V; Pop-Jordanova N; Zatkova A
    Prilozi; 2011; 32(1):305-11. PubMed ID: 21822197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of nitisinone in patients with alkaptonuria.
    Suwannarat P; O'Brien K; Perry MB; Sebring N; Bernardini I; Kaiser-Kupfer MI; Rubin BI; Tsilou E; Gerber LH; Gahl WA
    Metabolism; 2005 Jun; 54(6):719-28. PubMed ID: 15931605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analyses of the HGO gene mutations in Turkish alkaptonuria patients suggest that the R58fs mutation originated from central Asia and was spread throughout Europe and Anatolia by human migrations.
    Uyguner O; Goicoechea de Jorge E; Cefle A; Baykal T; Kayserili H; Cefle K; Demirkol M; Yuksel-Apak M; Rodriguez de Córdoba S; Wollnik B
    J Inherit Metab Dis; 2003; 26(1):17-23. PubMed ID: 12872836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of tyrosine pathway enzymes in mice demonstrates that homogentisate 1,2-dioxygenase deficiency in the liver is responsible for homogentisic acid-derived ochronotic pigmentation.
    Wilson PJM; Ranganath LR; Bou-Gharios G; Gallagher JA; Hughes JH
    JIMD Rep; 2021 Mar; 58(1):52-60. PubMed ID: 33728247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homogentisate 1,2-dioxygenase (HGD) gene variants in young Egyptian patients with alkaptonuria.
    Abdelkhalek ZS; Mahmoud IG; Omair H; Abdulhay M; Elmonem MA
    Sci Rep; 2023 Sep; 13(1):14374. PubMed ID: 37658095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation spectrum of homogentisic acid oxidase (HGD) in alkaptonuria.
    Vilboux T; Kayser M; Introne W; Suwannarat P; Bernardini I; Fischer R; O'Brien K; Kleta R; Huizing M; Gahl WA
    Hum Mutat; 2009 Dec; 30(12):1611-9. PubMed ID: 19862842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.